Strokeppt 170720174010
Strokeppt 170720174010
Strokeppt 170720174010
Presentation on :
STROKE
STROKE
OUTLINE
Introduction
Types & Risk Factors of Stroke
Pathophysiology of Stroke
Investigations
STROKE
PROGRESSING/
EVOLVING COMPLETED TIA
TIA(Transient ischemic attack):A clinical syndrome of
rapid onset of focal deficits of brain function, which
resolves with in 24 hours,regardless of whether there’s
imaging evidence of new permanent brain injury.
PROGRESSIVE STROKE:A stroke in which focal
neurological deficits worsen with time.
Also called stroke in evolution.
o COMPLETED STROKE:A stroke in which the focal
neurological deficits persists & donot worsen with time.
TYPES & RISK FACTORS
RISK FACTORS
Fixed o Modifiable
Age High blood pressure
Gender( male> female) Heart disease(atrial
Race(Asian>european) fibrillation, heart failure,
Heredity endocarditis)
Diabetes mellitus
Previous Vascular
event.eg: MI, peripheral Hyperlipidaemia
embolism Smoking
High fibrinogen Excess alcohol
consumption
Oral contraceptives
Social deprivation
Obesity, sedentary
lifestyle
TYPES OF STROKE
STROKE
Ischemic Haemorrhagic(1
stroke(85%) 5%)
Intracerebral Subarachnoid
Thrombotic Embolic(MC) haemorrhage
haemorrhage
TYPES OF STROKE
PATHOPHYSIOLOGY OF STROKE
Brain requires constant supply of glucose &
oxygen, delivered by blood.
Brain receives 15% of resting output & accounts for
20% of total body oxygen consumption.
Cerebral blood flow is maintained via auto
regulation. Thus the brain is highly aerobic tissue
where oxygen is limiting factor.
Blood flow
If zero leads to death of brain tissue within 4-10 mins
<16-18ml/100g tissue/min infarction with in an
hour.
<20ml/100gm tissue/min ischemia without infarction
unless prolonged for several hours or day.
HEMORRHAGIC STROKE
Two types
Intracerebral hemorrhage(ICH)
Subarachnoid hemorrhage(SAH)
SUBARACHNOID HEMORRHAGE
Prerequisites
Posterior circulation-Vertebral
artery, Basilar artery and Posterior
cerebral artery
ANTERIOR CIRCULATION STROKE
SYNDROMES
STROKE WITHIN THE ANTERIOR
CIRCULATION
o Clinical features
Contralateral hemiplegia – face and
limb.
o Clinical features
Contralateral hemianopia.
o Clinical features
Contralateral hemiplegia
Contralateral hemisensory loss
Contralateral gaze palsy
Contralateral hemianopia
Global dysphasia (Left sided lesion)
Anosognosia and amorphosynthesis
(Right sided lesion)
Altered sensorium (due to edema)
MIDDLE CEREBRAL ARTERY INFARCTION-
LENTICULOSTRIATAL OCCLUSION
Syndrome comprises
c/l hemiplegia
c/l hemianaesthesia
c/l homonymous hemianopia
POSTERIOR CIRCULATION STROKE
SYNDROMES
POSTERIOR CIRCULATION
Supplies
Cerebellum
Medulla
Pons
Midbrain
Thalamus
Subthalamus
Hippocampus
Occipital lobe
POSTERIOR CIRCULATION
LESIONS OF THE MEDULLA
Medial medullary syndrome
A.IPSILATERAL
B.CONTRALATERAL
A. IPSILATERAL
1.Xth cranial nerve palsy
2.Cerebellar signs
3.Horner’s syndrome
4.Impaired pain, temperature
and touch On the upper half
of face
B. CONTRA LATERAL
1.Impaired pain and temperature
over the body
BASILAR ARTERY
Paramedian- wedge of pons in midline.
Lesions result in
contralateral spastic hemiparesis.
Medial lemniscus
Lesions result in
contralateral loss of tactile sensation from the trunk
extremities.
Abducent nerve roots
Lesions result in
ipsilateral lateral rectus paralysis.
LATERAL INFERIOR PONTINE SYNDROME
anterior inferior cerebellar artery (AICA) syndrome
Affected structures and resultant deficits include--
facial nucleus and intraaxial nerve fibers
Clinical features
1.Ipsilateral
2.Contralateral
a.hemiplegia
BENEDIKT SYNDROME-OCCLUSION OF PERFORATING
BRANCH OF POSTERIOR CEREBRAL
Clinical features
1.Ipsilateral
2.Contralateral
a.cerebellar ataxia
DORSAL MIDBRAIN (PARINAUD'S) SYNDROME
-paralysis of upward and
downward gaze
-pupillary disturbances
(Pseudo-
Argyll Robertson pupils)
-absence of convergence
(Convergence-Retraction
nystagmus on Attempts
at upward gaze)
-noncommunicating hydrocephalus
DIFFERENTIATING FEATURES BETWEEN ANTERIOR
AND POSTERIOR CIRCULATION STROKE
Clinical features Posterior circulation Anterior circulation
A.History
1.Vertigo Present Absent
2.Unsteadiness Present Absent
B.Physical findings
1.Crossed hemiplegia Present Absent
Clotting Screen.
MR Angiography (Cerebral
Doppler Ultrasound Arteriography)
EEG CT Angiography
PET
SPECT
CT SCAN
Mandatory initial investigation
Haemorrhage appears instantly as a hyperdense
area
Infarct appears as a hypodense area
Infarct may not appear before 48 hrs
MRI may be done instead but ct scan is more
sensitive for detecting haemorrhage
Diffusion weighted MRI is good for identifying
ischaemic lesion.
SAH
ISCHEMIC
STROKE
STROKE PATIENT
CT SCAN/MRI
VASCULAR NATURE
CONFIRMED
ISCHAEMIA
HAEMORRHAGE
CEREBRAL
ARTERIOGRAPHY MRA/CTA DOPPLER PET/SPECT
NORMAL CT SCAN
HAEMORRHAGE
SUSPECTED
LUMBAR PUNCTURE
HAEMORRHAGE CONFIRMED
TREATMENT OBJECTIVES
1. Minimize volume of brain reversibly damaged
2. prevent complications
3. Rehabilitation
1. Stop smoking
2. Concurrent medical problems to be addressed:
Emboli from heart and other parts of cardiovascular
system
(a) anti coagulants: Heparin(IV), Warfarin(oral)
(b) anti platelet drugs: Aspirin(oral), Ticlopidine
Diabetes, Hypertension, Hyperlipidemia
MANAGEMENT OF A TRANSIENT
ISCHAEMIC ATTACK(TIA) – CONT’D
SURGICAL MANAGEMENT
CAROTID AND CEREBRAL ARTERIOGRAPHY
STENOSIS
NEUROPROTECTIVE AGENTS.
ANTI PLATELET THERAPY
Asprin, Clopidogrel
- act by inhibiting platelet aggregation and
adhesion.
- aspirin 300mg single dose to be given
immediately following diagnosis.
- if alteplase given it can be with held for 24 hrs.
- later aspirin at a dose of 75 mg in combination
with clopidogrel 75 mg daily for about one year
duration.
ANTI COAGULANTS
HEPARINS , WARFARIN
-heparins act by accelerating the inhibition of factor II and factor X
of coagulation cascade
-warfarin antagonises vitamin K to prevent activation of clotting
factors
-decrease risk of recurrence and venous thromboembolism
-intra cranial haemorrhage to be excluded before therapy
-more useful if stroke is evolving
HYPEROSMOLAR AGENTS
- reduce cerebral oedema
- 20% mannitol IV – 100ml TID
- oral glycerol if swallow is normal
Concurrent medical problems such as atrial fibrillations to be
tackled
OTHERS:
- PENTOXYPHYLLINE to be used within 12 hrs
-NEUROPROTECTIVE AGENTS
HAEMORRHAGIC STROKE
Control of hypertension
Control coagulation abnormalities (esp due to oral
anticoagulants)
Surgical decompression
Surgery for aneurysms and arterio-venous
malformations
Anti platelet and anti coagulants are
contraindicated
REHABILITATION
Physiotherapy - as early as possible
Occupational therapy
Speech therapy
Lipid Management
Smoking Cessation
Alcohol Moderation
Statins
oAccompanying fever
oHypotension
oLow oxygen saturation
oHypoglyemia & hyperglycemia
oPontine haemmorhage
oLow gcs score
oHeart failure
oSeverity of hemiparesis
PROGNOSIS
ISCHAEMIC STROKE
Mortality rate in first 30 days is 8-12%
INTRACEREBRAL HAEMORRHAGE
Mortality rate in first 30 days is almost 50%
Site and extent of hematoma also plays a role in
determining the prognosis
Hamorrhagic strokes have a poor prognosis compared
to ischaemic type .